United States · FDA National Drug Code directory

Guaifenesin

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 76162-031_df5d7fac-fdbc-4ebd-bcb9-0e67a891101f
Product NDC: 76162-031
Form: TABLET, EXTENDED RELEASE
Composition / generic term: Guaifenesin
Labeler: TOPCO ASSOCIATES LLC
Marketing category: ANDA
Marketing start / end (source format): 20260422
Source listing expiry: 20271231

Source-listed ingredients

GUAIFENESIN — 1200 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

4 BLISTER PACK in 1 CARTON (76162-031-56) / 14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 76162-031-56

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →